Cannara Biotech8CB0 
$0.44-5.66%24h
-5.66%24h
Global rank26472
Market cap$39.70M
Change 7d-5.21%
YTD Performance-27.93%
SP500 benchmarkUnderperform
P/E5.56
P/S0.94
Revenue$42.06M
Earnings$5.10M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech (8CB0) Cash on Hand
8CB0 Cash on Hand in 2022: $3.14M
According to Cannara Biotech latest financial reports the cash on hand of 8CB0 is $3.14M, an decrease of -64.75% to 2022. At the end of 2022 company had $8.90M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
8CB0 Cash on Hand History from 2019 to 2023
-
Value:-
8CB0 Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $3.14M | -64.75% |
| 2022 | $8.90M | 48.48% |
| 2021 | $5.99M | 4.99% |
| 2020 | $5.71M | -70.68% |
| 2019 | $19.47M | - |
View the Top Cash on Hand Companies 
